Therefore, ACE2-deficient mice provide a suitable model for assessing the pathophysiological relevance of NAFLD and represent an excellent tool to investigate new therapeutic strategies for MetS as well as associating disorders. The gene discussed is ACE2; the disease is metabolic syndrome.